Let’s stir up some magic in the lab with a very hot topic for indie beauty brands: who owns your formulas?

Launching or scaling a beauty brand is exhilarating, but nothing stalls momentum faster than confusion over who actually owns your formula. Understanding what cosmetic IP rights means in practice impacts valuation, fundraising, manufacturer choice, speed to market and even your ability to expand internationally. In 2025 and moving into 2026, with retailers tightening requirements and regulations evolving across the EU, UK, US and beyond, clarity on formula ownership is not just nice to have. It is operational oxygen.

Below, we unpack three common scenarios you will encounter with labs and manufacturers. We translate the legal and technical jargon into plain English, show what you do and do not own in each case, and offer practical paths to protect your margin, timeline and brand equity.

Why formula ownership matters more than ever

Owning your formula is not about being precious. It is about control. If you do not control the composition, method and technical file behind your product, then you do not control your production schedule, your cost of goods, your ability to meet retailer onboarding, or your brand’s exit value. Investors and acquirers look for defensibility, repeatability and portability. A brand built on full IP cosmetic formulations that can be manufactured at multiple qualified sites using documented methods is a brand with options.

There is also a regulatory dimension. In the EU and UK, your Product Information File must reflect the exact composition, manufacturing method and safety assessment for the product you place on the market. In the US, MoCRA pushed brands to formalise product records, adverse event tracking and facility registration. If your manufacturer holds all formulation knowledge and you lack a signed pathway to access it, small changes can snowball into delays, rework and expensive re-testing.

Scenario 1: Private label or white label

Under private label, the manufacturer offers you a pre-existing formula. You choose the format, fragrance, packaging and artwork. You launch quickly and cheaply. It is a brilliant model for testing a concept, building a seasonal range, or filling a gap ahead of a retail pitch.

However, you do not own the formula. From a legal standpoint, this is where many founders misunderstand what cosmetic IP rights means. You are effectively licensing the right to buy and sell that composition from that manufacturer. Other brands may sell the same or a very similar base under different names. Even if you requested minor tweaks, the formula remains the manufacturer’s trade secret.

What you typically receive: an INCI list in descending order for labelling, a safety profile for claims clearance and, for EU brands, the CPNP reference number of the product to be used on your own CPNP notification. You may receive a specification sheet with pH, viscosity and microbiological limits. You do not receive formula percentages or the detailed manufacturing method.

What you cannot do: you cannot take that exact product to a different manufacturer. If you outgrow the partner or need additional capacity, you must reformulate or reverse engineer. Reverse engineering rarely delivers a true replica and will trigger fresh testing.

When private label makes sense: early-stage validation, limited editions, giftable sets and situations where speed matters more than differentiation.

Scenario 2: Partial development or base with changes

This option sits between private label and ownership. The manufacturer starts from a house base and applies agreed changes such as swapping actives, adjusting texture or changing fragrance. You usually pay a development fee and benefit from a proven base.

Ownership remains with the manufacturer. You may own the specific additions you paid for, but not the base itself. This means you still do not have full IP cosmetic formulations, and production remains tied to that lab.

Partial development makes sense when timelines are tight and differentiation is needed without full redevelopment.

Scenario 3: Full development with full IP transfer

This is where ownership becomes clear. You commission a formula to your brief and purchase the intellectual property. You own the composition at percentage level, the method and the technical documentation. This is what full IP cosmetic formulations look like in practice.

What you should receive: the complete formula, manufacturing method, specifications, raw material documentation, stability and challenge testing summaries and a full tech transfer package. This documentation allows you to move production, scale confidently and satisfy regulatory and retail scrutiny.

This route unlocks stronger cost negotiation, supply resilience, smoother retailer onboarding and higher brand valuation.

Cost, time and risk

Private label has the lowest upfront cost and fastest launch. Partial development balances speed and differentiation. Full ownership requires more investment but protects long-term value. Brands that understand what cosmetic IP rights means early avoid expensive rework later.

Contracts and future-proofing

Ownership must be explicitly defined in writing. If you commission full development, your agreement should confirm transfer of IP upon final payment. For partial development, define what elements can be ported or bought out later.

Documentation transfer, confidentiality clauses and compliance responsibilities should be clear from the outset.

Moving from private label to owned IP

Many brands transition over time. Start by identifying what customers love about the current product and brief a chemist to replicate the sensorial experience while building toward full IP cosmetic formulations. Overlap production and testing to avoid stock gaps and communicate upgrades clearly to customers.

A simple decision guide

Choose private label for speed and validation.

Choose partial development for controlled differentiation.

Choose full development when your product is central to your brand story and long-term value.

Understanding what cosmetic IP rights means is not about legal theory. It is about building a brand that can grow, adapt and be taken seriously by retailers, regulators and investors alike.

Here’s to formulas that work and brands that thrive.

From my lab to yours,

Rose